Anti-tumor action of trichosanthin, a type 1 ribosome-inactivating protein, employed in traditional Chinese medicine: A mini review
Publication in refereed journal

替代計量分析
.

其它資訊
摘要Trichosanthin (TCS) as a midterm abortifacient medicine has been used clinically in traditional Chinese medicine for centuries. Additionally, TCS manifests a host of pharmacological properties, for instance, anti-HIV and anti-tumor activities. TCS has been reported to inhibit cell growth of a diversity of cancers, including cervical cancer, choriocarcinoma, and leukemia/lymphoma, etc. This article purported to review the various anti-tumor activities of TCS and the mechanism of apoptosis it induced in these tumor cells. These research progresses provide an insight into cancer research and treatment as well as disclose new pharmacological properties of the ancient but popular Chinese medicine. © 2013 The Author(s).
著者Sha O., Niu J., Ng T.-B., Cho E.Y.-P., Fu X., Jiang W.
期刊名稱Cancer Chemotherapy and Pharmacology
詳細描述To ORKTS: doi: 10.1007/s00280-013-2096-y
出版年份2013
月份6
日期1
卷號71
期次6
出版社Springer Verlag
出版地Germany
頁次1387 - 1393
國際標準期刊號0344-5704
電子國際標準期刊號1432-0843
語言英式英語
關鍵詞Anti-tumor, Apoptosis, Ribosome-inactivating protein, Trichosanthin (TCS)

上次更新時間 2021-16-06 於 00:11